Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The SUMMIT trial took this further with tirzepatide, showing a 38% reduction in the composite of cardiovascular death or worsening heart failure (HR 0.62) in patients with HFpEF and obesity, along with a clinically meaningful 6.9-point improvement in KCCQ scores
This article walks through what the clinical and mechanistic research actually shows about probiotics and GLP-1: how gut bacteria influence the hormone naturally, whether probiotics can meaningfully support people on GLP-1 medications, which strains have real evidence behind them, and how to think about fiber, timing, and safety
Understanding these variables can help healthcare professionals identify patients who may require additional support or modified treatment approaches
Alpha & Eden BPC-157 is supplied as a high-purity lyophilized powder for controlled research applications
